Literature DB >> 21625343

Investigations of the {ReO} core: A '2+2' complex from bidentate and potentially trident ligands: [ReO(η-HOC(6)H(4)-2-CH(2)NC(6)H(4)S)(η-SC(5)H(4)N)(PPh(3))].

Xiaoyuan Chen1, Frank J Femia, John W Babich, Jon Zubieta.   

Abstract

The reaction of [ReOCl(3)(PPh(3))(2)] with N-(2-hydroxybenzyl)-2-mercaptoaniline (H(3)hbma) (2) and 2-mercaptopyridine in hot CHCl yields [ReO(η(2)-HOC(6)H(4)-2-CH(2)NC(6)H(4)S)(η(2)-SC(5)H(4)N)(PPh(3))] (3). The structure of 3 consists of distorted octahedral Re(V) monomers. The coordination geometry at the rhenium is defined by a terminal oxo-group, the nitrogen and sulfur donors of the chelating mercaptopyridine, the nitrogen and sulfur donors of a bidentate (Hhbma)(2-) ligand, and the phosphorus of the PPh(3) group. The -C(6)H(4)OH arm of (Hhbma)(2-) is pendant, and the coordinated nitrogen of this ligand is present as a deprotonated amido nitrogen.

Entities:  

Year:  2000        PMID: 21625343      PMCID: PMC3103089          DOI: 10.1016/S0020-1693(00)00146-8

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  5 in total

1.  Therapeutic radiopharmaceuticals.

Authors:  W A Volkert; T J Hoffman
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

Authors:  Frank J Femia; Xiaoyuan Chen; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-04-20       Impact factor: 2.545

Review 3.  Vehicles, chelators, and radionuclides: choosing the "building blocks" of an effective therapeutic radioimmunoconjugate.

Authors:  P A Schubiger; R Alberto; A Smith
Journal:  Bioconjug Chem       Date:  1996 Mar-Apr       Impact factor: 4.774

4.  Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.

Authors:  J P DiZio; R Fiaschi; A Davison; A G Jones; J A Katzenellenbogen
Journal:  Bioconjug Chem       Date:  1991 Sep-Oct       Impact factor: 4.774

Review 5.  Therapeutic radionuclides: production and decay property considerations.

Authors:  W A Volkert; W F Goeckeler; G J Ehrhardt; A R Ketring
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

  5 in total
  1 in total

1.  The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

Authors:  Xiaoyuan Chen; Frank J Femia; John W Babich; Jon Zubieta
Journal:  Inorganica Chim Acta       Date:  2000-10-20       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.